Mayo Clinic
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Mayo Clinic sits in the top decile of US sponsors by registered trial count (#2 of 15,751 sponsors by registered trial count).
Mayo Clinic: 2,844 sponsored US clinical trials, 544 recruiting.
Mayo Clinic sponsors 2,844 registered US clinical trials on ClinicalTrials.gov, 544 of them currently recruiting, and 1,816 completed. 252 of these trials are in Phase 3-4 (later-stage) and 821 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 36 trials.
Top-decile sponsor footprint
Mayo Clinic ranks in the top decile of sponsors by registered trial count (#2 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
2,844 total, page 54 of 57
Pilot Study of Rituximab for Membranoproliferative Glomerulonephritis
NCT00275613
Adapting Web-based Instruction to Baseline Knowledge of Physicians-in-training
NCT00466453
Topical Steroid Treatment for Eosinophilic Esophagitis
NCT00275561
Use of MRI for Assessing Stomach Relaxation in Response to a Meal
NCT00275743
Docosahexaenoic Acid in the Treatment of Autism
NCT00577447
Evaluation of Respiratory Specimens for Bacterial and Viral Pathogens by Real-Time PCR
NCT00275691
Determining the Amount of Time Needed for Nelfinavir to Boost the Immune System in Adults
NCT00346619
The Study of Long-term Deterioration of Kidney Transplants.
NCT00217126
Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis
NCT00477971
Short Term Relief of Eustachian Tube Dysfunction and Serous Otitis Media Using Intranasal Steroid Sprays
NCT00279916
Intervention for Support Persons to Help Smokers Quit
NCT00379054
The Utility of Levofloxacin-Rifampin in the Therapy of Prosthetic Joint Infection
NCT00279864
Samarium Sm 153 Lexidronam Pentasodium and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
NCT00478075
Effect of Branched Chain Amino Acids on Muscle
NCT00170144
Smoking Cessation for Young Adults Who Binge Drink - 1
NCT00218452
An Intervention to Preserve Functional Status and Independence Among Community Dwelling Elderly
NCT00217113
Endoscopic Therapy of Early Cancer in Barretts Esophagus
NCT00217087
Effects of Tolterodine, a Non-Specific Muscarinic Antagonist, on Gastrointestinal Transit in Healthy Subjects
NCT00332137
St. John's Wort for Tobacco Cessation
NCT00405912
Bortezomib in Treating Patients With Advanced Myeloproliferative Disorders
NCT00437086
ABI-007 (Nab-Paclitaxel) and Gemcitabine in Treating Women With Metastatic Breast Cancer
NCT00110084
Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment
NCT00436618
Pre-biopsy With Dynamic Acquisitions
NCT00943644
Green Tea Extract in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia
NCT00262743
Posturing Effects on Perception of Time and Perceptions of the Provider-Patient Interaction in the Emergency Department
NCT00170105
Effect of Insulin Sensitizer Therapy on Atherothrombotic and Inflammatory Profiles Associated With Insulin Resistance
NCT00443755
Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts
NCT00620373
Use of the PSA 4000 Monitor in the Post-Operative Period in Patients Undergoing Major Surgery
NCT00273169
Topical Agent for Treatment of Red Skin
NCT00279890
Comparing Two Ways of Controlling Blood Sugar With Insulin in Patients Admitted to the Intensive Care Unit
NCT00166491
Pharmacogenetics of Anastrozole in Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Stage I, Stage II, or Stage III Breast Cancer
NCT00283608
A Study of the Effect of Lenalidamide on Complex Regional Pain Syndrome Type 1
NCT00166452
A Phase II/III Study of Continuous Local Anesthetic Infusion in Median Sternotomy Following Cardiac Surgery
NCT00586976
Near Infrared Light for the Treatment of Painful Peripheral Neuropathy
NCT00125268
Effect of Yohimbine on Colon Transit
NCT00217048
Comparison of Sirolimus to Tacrolimus for Long Term Therapy in Kidney Transplant With no Steroids
NCT00170053
Effect of the Dietary Supplement SAMe on Blood Homocysteine Levels
NCT00284011
A Comparison Between Full Thickness and Partial Thickness Corneal Transplantation for Corneal Edema
NCT00346138
Melphalan, Prednisone, and Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
NCT00477750
Effects of Motivational Interviewing on Self-Efficacy and Standardized Low Back Pain Outcomes in Patients With Chronic Back Pain"
NCT00170118
Treatment of Breast Pain Using A Medication (Diclofenac) Applied to the Skin
NCT00276419
Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan, Melphalan, and Autologous Peripheral Stem Cell Transplant in Treating Patients With Previously Treated Multiple Myeloma
NCT00477815
Studying Biomarkers in Nipple Fluid, Urine, and Blood Samples From Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer and in Women at Risk of Developing Breast Cancer
NCT00897208
Flaxseed for the Treatment of Hot Flashes
NCT00275704
The Effects of LAF237 on Gastric Function in Type 2 Diabetes
NCT00952991
A Trial to Study How the Body Fights Off Cytomegalovirus (CMV) in Hematopoietic Transplant Recipients.
NCT00273143
Role of Endothelin in Microvascular Dysfunction Following PCI for NSTEMI
NCT00586820
Effect of a Decision Aid About Statin Use in Patients With Type 2 Diabetes Mellitus
NCT00217061
Efficacy of CC-5013 (Revlimid or Lenalidomide) in Patients With Primary Systemic Amyloidosis
NCT00166413
Which Supraesophageal Reflux Symptoms Reliably Respond to Proton-Pump-Inhibitor (PPI) Therapy
NCT00170001
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 435 |
| Phase 2 | 386 |
| Phase 3 | 86 |
| Phase 4 | 166 |
Therapeutic Areas
What is open in the Mayo Clinic pipeline
544 recruiting of 2,844 indexed (19% open); 1,816 completed (64%).
Phase mix: 252 late (III/IV) vs 821 early (I/II) (early-phase heavy).
Top condition: Healthy (36 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.